AbstractHIVViral Hepatitis and Liver DiseasePuerto Rico Meeting on Hepatitis & HIV 2019Clinical case presentation: A preliminary profile of common co-morbidities and risk practices in a sample of HIV/HCV co-infected patients in Puerto RicoView Abstract
AbstractHIVViral Hepatitis and Liver DiseasePuerto Rico Meeting on Hepatitis & HIV 2019A phase 3b, open-label, pilot study to evaluate switching to elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (E/C/F/TAF) in virologically suppressed HIV-1 infected adult subjects harboring the NRTI resistance mutation M184V and/or M184I (GS-USView Abstract
AbstractHIVViral Hepatitis and Liver DiseasePuerto Rico Meeting on Hepatitis & HIV 2019Acceptability and concerns over the use of PrEP in Puerto RicoView Abstract
SlidesetINTEREST 2019PopART in Zambia and South Africa: What Have We Learned? - Albertus Schaap, MScView Slideset
SlidesetINTEREST 2019Characterizing the HIV Epidemic among 15-24 Year Olds in Urban Ethiopia, 2017-18 - Aderonke AjiboyeView Slideset
SlidesetINTEREST 2019Economic Burden of Accessing Treatment on People Living with HIV; Outcomes of a Cross-Sectional Survey in Lagos State, Nigeria - Adewale OgunnaikeView Slideset
SlidesetINTEREST 2019Application of Machine Learning Models in Prediction of PrEP Retention among High-risk Persons in Uganda - Agnes KiraggaView Slideset
SlidesetINTEREST 2019Prevalence of Cervical HPV Infection among Women Living with HIV in Harare, Zimbabwe - Ardele Maureen MandiririView Slideset
SlidesetINTEREST 2019Factors Associated with Liver Injury among HIV Infected Children and Adolescents Attending a National Referral Pediatric HIV Clinic in Uganda - Bonny MulindwaView Slideset
SlidesetINTEREST 2019Three Billboards on West African Adolescent HIV Prevention Studies: Rights, Complexities and Possible Solutions - Ann Strode, BA, LLB, LLM, PhDView Slideset
